Hui Feng, MD, PhD, Promotion to Associate Professor

Congratulations to Hui Feng, MD, PhD, in the Department of Pharmacology & Experimental Therapeutics and the Department of Medicine, Section of Hematology Oncology, for her promotion to Associate Professor! Dr. Feng established the Zebrafish Genetics and Cancer Therapeutics Laboratory using zebrafish to genetically screen for potential therapeutic targets for human cancers. To learn more about Dr. Feng’s […]

Julie Palmer Named Karin Grunebaum Cancer Research Professor

Congratulations to Julie Palmer, ScD, MPH, Co-Director of the BU-BMC Cancer Center, Associate Director of the Slone Epidemiology Center and Professor of Medicine and Epidemiology, for being named as the Karin Grunebaum Cancer Research Professor, which was established in 2002 by the Karin Grunebaum Cancer Research Foundation. Read more: http://www.bumc.bu.edu/busm/2019/04/18/julie-palmer-named-karin-grunebaum-cancer-research-professor/ About the Award In June 1958, at age […]

Boston Magazine’s 2019 Top Doctors

Boston Magazine‘s annual Top Doctors issue has hit newstands and the section is well represented. Congratulations to the following faculty members on this well deserved recognition: Hematology Vaishali H. Sanchorawala Medical Oncology Gretchen Gignac Kevan L. Hartshorn Matthew H. Kulke Adam Lerner

BMC Breast Cancer Team Travels to San Antonio Breast Cancer Symposium

  Our multidisciplinary BMC breast cancer team traveled to San Antonio, Texas this December to attend the San Antonio Breast Cancer Symposium to present research projects, continue research collaborations and join colleagues around the world to learn about the latest in breast cancer research and treatment.  Pictured here are Dr. Michael Cassidy (Surgical Oncology), Dr. Naomi Ko (Medical […]

Guillaume Andrieu PhD and Jordan Shafran report research on new mechanisms to develop immunotherapy for triple negative breast cancer

      The research team of Andrieu and Shafran, directed by Gerald Denis PhD, in the BU-BMC Cancer Center, has just reported that “BET bromodomain targeting suppresses the PD-1/PD-L1 pathway in triple-negative breast cancer and elicits anti-tumor immune response”, which appeared today in Cell Reports ‘Sneak Peek’ https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3260754 The mechanisms that control the expression […]